about
Efficacy of antidepressants in adultsProteomic analysis of rat hippocampus exposed to the antidepressant paroxetineThe development, evolution and philosophy of a clinical research unit.International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.A comparison of placebo responders and nonresponders in subgroups of depressive disorder.Efficacy of venlafaxine in the treatment of severe depression.Lithium psychiatry : therapeutic efficacy, side effects and practical issues.Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews.Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram.Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorderImpact of tryptophan metabolism on the vulnerability to alcohol-related blackouts and violent impulsive behaviours.Compulsive personality as predictor of response to serotoninergic antidepressantsThe biology of personality.Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical casesDepression With Atypical Features: Diagnostic Validity, Prevalence, and TreatmentP300 findings for depressive and anxiety disorders.Genes and environment: nosology and psychiatry.Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.What moderator characteristics are associated with better prognosis for depression?Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice.Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.Anxiety, depression, and substance use disorders: diagnosis, treatment, and prescribing practices.Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects.Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Nonremission and time to remission among remitters in major depressive disorder: Revisiting STAR*D.The prediction of response in the anxiety disorders.Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral.Treatment of acute bipolar depression: a review of the literature.The recognition and treatment of late-life depression: a view from primary care.Depressive illness and the possibilities of somatic antidepressant treatment.Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.Eating disorders and antecedent anxiety disorders: a controlled study.Predictors of response to monoamine oxidase inhibitors: do they exist?The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.Natural history of symptoms of depression and anxiety during inpatient treatment on general medicine wards.
P2860
Q24555325-72740A34-0FD4-414F-B7C3-8FB0E2316595Q28567997-2DD0CA10-A931-48F6-A87D-63CC28A617A6Q30330436-59ED581B-9878-4AB2-8503-BB17B24B12ADQ30433255-A9270B5F-1CED-4281-AC7A-9B8AAB5301E0Q33404025-0B3AD065-31D8-4F35-9C57-7FF05946C33BQ33921573-3EB9B35D-68BE-4A46-91A7-82274CC4BFC3Q34093702-FA17D2A6-D588-4DA4-94DE-94EC6A6C61B8Q34333431-D520863B-7317-45B3-98B4-635D122A5FE1Q34396650-BED7160A-4307-4A72-A24D-C1D603A32A38Q34560707-63E202EA-9B8A-4729-B4C5-D75F477EF9C7Q34607784-A9E51862-89C5-44AE-98D7-DD1A03A95382Q34611934-F7C67A2E-032D-4400-A818-2E8912FA0516Q35180867-53E2D242-885B-475E-9E4D-9A1631EC382BQ35268319-7F802CC4-CADA-4600-AF48-DF4F06AE4529Q35636163-A96FBF2C-5BD4-4278-BE1F-580E663C60D8Q35667204-90C87B58-ABA4-4F90-B4D7-905237A0691AQ35670923-6686D26F-713E-413E-BB8C-F6245A5DCFD3Q35796553-A0675A21-B6A7-40D0-A318-4F2BE21B5165Q36007894-91D102DB-0104-4936-AFBB-E5679B73DF0FQ36718042-71F4344E-6E0F-4603-96D0-29E23DF5C968Q36827434-78C52155-08AC-4F8E-8367-BC92656E19E7Q36892482-65834498-7EAE-42B2-A266-10ECF398A76BQ37042411-530121BA-BB7E-49A3-9F2E-32C51290B2BEQ37158256-A621F71F-3B8E-440F-A08D-A6E99A7D1013Q37161019-812A049B-7721-495F-B9DC-2007787EC890Q37989490-BC87201C-D8DC-4EAB-9F49-966B677B8B1DQ38611868-987460D2-96EC-412B-900F-4A95B1A60A7EQ38768842-70FD29A8-B4A1-4D3A-84BF-F8730C9F2823Q39206756-48FCDCC8-745A-4469-ABCF-950A352513E0Q40954013-234D34CB-A45B-4D44-A0E4-E3814980D138Q40957072-B9F7D6FB-E814-4A35-8150-1267954DEDC5Q41459287-A0727EB7-3F8E-4837-93C3-C94D05807581Q44024568-FB48ADFE-3790-4EFC-A674-B909E4DB84CBQ44024571-A24DB489-A273-428C-BA3F-C148938AC1FFQ44662293-B5D19C4D-9824-4532-9883-B895C82F9190Q44967605-A23C15BF-2997-476B-B75A-3F7ECEE5B94EQ45106444-83DCCF48-BDE6-414A-9363-05C44EA0201CQ45184472-5BADC750-864A-4441-9791-A597433A1702Q45300509-A2D033C9-BD17-4397-B03D-178F7D2A1DEAQ45416960-A602C3DF-53D3-487F-9103-45D499EB2A49
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Predictors of drug response in depression.
@en
type
label
Predictors of drug response in depression.
@en
prefLabel
Predictors of drug response in depression.
@en
P1433
P1476
Predictors of drug response in depression.
@en
P2093
P356
10.1001/ARCHPSYC.1989.01810010091014
P407
P577
1989-01-01T00:00:00Z